Mycoplasma pneumoniae: Current knowledge on macrolide resistance and treatment.
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, mutations at nucleotide positions A2063G and A2064G in the 23S rRNA, along with alterations in ribosomal proteins L4 and L22, hinder macrolide binding to the ribosome, leading to loss of drug efficacy (Pereyre et al., 2016).”
From Advances in adhesion-related pathogenesis in Mycoplasma pneumoniae infection (2025) · cites this paper as Pereyre et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 93
- Akaike, 2012, In vitro activities of 11 antimicrobial agents against macrolide-resistant Mycoplasma pneumoniae isolates from pediatric patients: results from a multicenter surveillance study, Jpn. J. Infect. Dis., 65, 535, 10.7883/yoken.65.535 · doi:10.7883/yoken.65.535
- Atkinson, 2008, Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections, FEMS Microbiol. Rev., 32, 956, 10.1111/j.1574-6976.2008.00129.x · DOI · Paper page
- Atkinson, 2011, Stevens-Johnson syndrome in a boy with macrolide-resistant Mycoplasma pneumoniae pneumonia, Pediatrics, 127, e1605, 10.1542/peds.2010-2624 · DOI
- Averbuch, 2011, Macrolide resistance, Mycoplasma pneumoniae, Israel, 2010. Emerging Infect. Dis., 17, 1079, 10.3201/eid/1706.101558 · doi:10.3201/eid/1706.101558
- Bebear, 2012, Editorial commentary: infections due to macrolide-resistant Mycoplasma pneumoniae: now what?, Clin. Infect. Dis., 55, 1650, 10.1093/cid/cis791 · doi:10.1093/cid/cis791
- Bébéar, 2005, Antimicrobial therapy and antimicrobial resistance, Mycoplasmas Molecular Biology Pathogenicity and Strategies for Control, 535
- Bébéar, 2005, Mechanisms of drug resistance, Mycoplasma pneumoniae. Curr. Drug Targets Infect. Disord., 5, 263, 10.2174/1568005054880109 · doi:10.2174/1568005054880109
- Bébéar, 2011, Mycoplasma pneumoniae: susceptibility and resistance to antibiotics, Future Microbiol., 6, 423, 10.2217/fmb.11.18 · DOI · Paper page
- Benitez, 2012, Multilocus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical isolates from 1962 to the present: a retrospective study, J. Clin. Microbiol., 50, 3620, 10.1128/JCM.01755-12 · DOI
- Bissessor, 2015, Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort, and response of azithromycin failures to alternative antibiotic regimens, Clin. Infect. Dis., 60, 1228, 10.1093/cid/ciu1162 · DOI · Paper page
- Bradley, 2011, The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, Clin. Infect. Dis., 53, e25, 10.1093/cid/cir531 · DOI · Paper page
- Brown, 2015, Detection of macrolide resistant Mycoplasma pneumoniae in England, September 2014 to September 2015, Euro. Surveill., 20, 30078, 10.2807/1560-7917.ES.2015.20.48.30078 · doi:10.2807/1560-7917.es.2015.20.48.30078
- Cao, 2010, High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China, Clin. Infect. Dis., 51, 189, 10.1086/653535 · DOI · Paper page
- Cardinale, 2013, Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children, J. Clin. Microbiol., 51, 723, 10.1128/JCM.02840-12 · DOI
- Cardinale, 2011, Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia, Eur. Respir. J., 37, 1522, 10.1183/09031936.00172510 · doi:10.1183/09031936.00172510
- Chalker, 2015, International Mycoplasma pneumoniae typing study: interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis, New Microb. New Infect., 7, 37, 10.1016/j.nmni.2015.05.005 · doi:10.1016/j.nmni.2015.05.005
- Chalker, 2012, Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012, Euro. Surveill., 17, 20081, 10.2807/ese.17.06.20081-en · doi:10.2807/ese.17.06.20081-en
- Chalker, 2011, Increased incidence of Mycoplasma pneumoniae infection in England and Wales in 2010: multilocus variable number tandem repeat analysis typing and macrolide susceptibility, Euro Surveill., 16, 19865, 10.2807/ese.16.19.19865-en · doi:10.2807/ese.16.19.19865-en
- Chironna, 2011, Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children, J. Antimicrob. Chemother., 66, 734, 10.1093/jac/dkr003 · DOI
- Couldwell, 2013, Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance, Int. J. STD AIDS., 24, 822, 10.1177/0956462413502008 · DOI · Paper page
- Critchley, 2002, In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe, Clin. Microbiol. Infect., 8, 214, 10.1046/j.1469-0691.2002.00392.x · doi:10.1046/j.1469-0691.2002.00392.x
- Dégrange, 2009, Development of multiple-locus variable-number tandem-repeat analysis for molecular typing of Mycoplasma pneumoniae, J. Clin. Microbiol., 47, 914, 10.1128/JCM.01935-08 · DOI
- Degrange, 2008, Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae, J. Antimicrob. Chemother., 61, 1390, 10.1093/jac/dkn118 · DOI
- Diaz, 2015a, Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States, Open Forum Infect. Dis., 2, ofv106, 10.1093/ofid/ofv106 · DOI
- Diaz, 2015b, Investigations of Mycoplasma pneumoniae infections in the United States: trends in molecular typing and macrolide resistance from 2006 to 2013, J. Clin. Microbiol., 53, 124, 10.1128/JCM.02597-14 · DOI
- Dumke, 2013, Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012, Antimicrob. Agents Chemother., 57, 3460, 10.1128/AAC.00706-13 · doi:10.1128/aac.00706-13
- Dumke, 2015, Mycoplasma pneumoniae and Chlamydia spp. infection in community-acquired pneumonia, Germany, 2011-2012, Emerg. Infect. Dis., 21, 426, 10.3201/eid2103.140927 · doi:10.3201/eid2103.140927
- Dumke, 2014, Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia, Int. J. Infect. Dis., 29, 197, 10.1016/j.ijid.2014.07.014 · doi:10.1016/j.ijid.2014.07.014
- Dumke, 2010, Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany, Clin. Microbiol. Infect., 16, 613, 10.1111/j.1469-0691.2009.02968.x · doi:10.1111/j.1469-0691.2009.02968.x
- Eshaghi, 2013, Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011, Emerg. Infect. Dis., 19, 1525, 10.3201/eid1909.121466 · doi:10.3201/eid1909.121466
- Esposito, 2011, Levofloxacin for the treatment of Mycoplasma pneumoniae-associated meningoencephalitis in childhood, Int. J. Antimicrob. Agents., 37, 472, 10.1016/j.ijantimicag.2011.01.008 · DOI
- Ferguson, 2013, Clinical outcomes and macrolide resistance in Mycoplasma pneumoniae infection in Scotland, UK, J. Med. Microbiol., 62, 1876, 10.1099/jmm.0.066191-0 · DOI
- Godron, 2013, Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection, Pediatr. Nephrol., 28, 2057, 10.1007/s00467-013-2541-5 · DOI
- Gruson, 2005, In vitro development of resistance to six and four fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, respectively, Antimicrob. Agents Chemother., 49, 1190, 10.1128/AAC.49.3.1190-1193.2005 · doi:10.1128/aac.49.3.1190-1193.2005
- Hantz, 2012, Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child, J. Clin. Microbiol., 50, 3402, 10.1128/JCM.01248-12 · DOI
- Harris, 2011, British Thoracic Society guidelines for the management of community acquired pneumonia in children: update, Thorax, 66, ii1, 10.1136/thoraxjnl-2011-200598 · DOI · Paper page
- Ho, 2015, Emergence of macrolide-resistant Mycoplasma pneumoniae in Hong Kong is linked to increasing macrolide resistance in multilocus variable-number tandem-repeat analysis type 4-5-7-2, J. Clin. Microbiol., 53, 3560, 10.1128/JCM.01983-15 · doi:10.1128/jcm.01983-15
- Hong, 2013, Macrolide resistance of Mycoplasma pneumoniae, South Korea, 2000-2011, Emerg. Infect. Dis., 19, 1281, 10.3201/eid1908.121455 · doi:10.3201/eid1908.121455
- Ishiguro, 2015, Regional differences in prevalence of macrolide-resistant Mycoplasma pneumoniae in Hokkaido, Japan, Jpn. J. Infect. Dis, 69, 186, 10.7883/yoken.JJID.2015.054 · DOI
- Ji, 2014, Single-nucleotide polymorphism PCR for the detection of Mycoplasma pneumoniae and determination of macrolide resistance in respiratory samples, J. Microbiol. Methods., 102, 32, 10.1016/j.mimet.2014.04.009 · doi:10.1016/j.mimet.2014.04.009
- Kawai, 2013, Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients, Antimicrob. Agents Chemother., 57, 4046, 10.1128/AAC.00663-13 · DOI
- Kogoj, 2015, Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014, Euro Surveill., 20, 30018, 10.2807/1560-7917.ES.2015.20.37.30018 · doi:10.2807/1560-7917.es.2015.20.37.30018
- Lin, 2010, Nested PCR-linked capillary electrophoresis and single-strand conformation polymorphisms for detection of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, J. Clin. Microbiol., 48, 4567, 10.1128/JCM.00400-10 · DOI
- Liu, 2010, Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China, Diagn. Microbiol. Infect. Dis., 67, 355, 10.1016/j.diagmicrobio.2010.03.004 · DOI
- Liu, 2012, Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis, J. Clin. Microbiol., 50, 2793, 10.1128/JCM.00678-12 · DOI
- Mandell, 2007, Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults., Clin. Infect. Dis., 44, S27, 10.1086/511159 · DOI · Paper page
- Matsubara, 2009, A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients, J. Infect. Chemother., 15, 380, 10.1007/s10156-009-0715-7 · doi:10.1007/s10156-009-0715-7
- Matsuda, 2013, Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan, BMC Infect. Dis., 13, 591, 10.1186/1471-2334-13-591 · doi:10.1186/1471-2334-13-591
- Matsuoka, 2004, Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan, Antimicrob. Agents Chemother., 48, 4624, 10.1128/AAC.48.12.4624-4630.2004 · DOI · Paper page
- Meyer Sauteur, 2014, Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland, Swiss Med. Wkly., 144, w14041, 10.4414/smw.2014.14041 · doi:10.4414/smw.2014.14041
- Meyer Sauteur, 2012, Neuroinvasive Mycoplasma pneumoniae infection without intrathecal antibody response, Pediatr. Infect. Dis. J., 31, 1199, 10.1097/INF.0b013e318266abff · DOI
- Miyashita, 2013, Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy, Antimicrob. Agents Chemother., 57, 5181, 10.1128/AAC.00737-13 · doi:10.1128/aac.00737-13
- Morozumi, 2008, Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia, Antimicrob. Agents Chemother., 52, 348, 10.1128/AAC.00779-07 · DOI · Paper page
- Morozumi, 2010, Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia, J. Infect. Chemother., 16, 78, 10.1007/s10156-009-0021-4 · DOI · Paper page
- Niitu, 1970, Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics, J. Pediatr., 76, 438, 10.1016/S0022-3476(70)80485-1 · DOI
- Nilsson, 2008, Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection, BMC Microbiol., 8, 93, 10.1186/1471-2180-8-93 · DOI · Paper page
- Okada, 2012, Rapid effectiveness of minocycline or doxyxycline against macrolide-resistant Mycoplasma pneumoniae infection in a outbreak among japanese children, Clin. Infect. Dis., 55, 1642, 10.1093/cid/cis784 · DOI · Paper page
- Pereyre, 2012, The spread of Mycoplasma pneumoniae is polyclonal in both an endemic setting in France and in an epidemic setting in Israel, PLoS ONE, 7, e38585, 10.1371/journal.pone.0038585 · doi:10.1371/journal.pone.0038585
- Pereyre, 2007, First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years, J. Clin. Microbiol., 45, 3534, 10.1128/JCM.01345-07 · DOI
- Pereyre, 2004a, In vitro, 48, 460, 10.1128/AAC.48.2.460-465.2004 · DOI
- Pereyre, 2004b, In vitro activities of the newer quinolones garenoxacin, gatifloxacin, and gemifloxacin against human mycoplasmas, Antimicrob. Agents Chemother., 48, 3165, 10.1128/AAC.48.8.3165-3168.2004 · doi:10.1128/aac.48.8.3165-3168.2004
- Pereyre, 2013, The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains, Clin. Microbiol. Infect., 19, E212, 10.1111/1469-0691.12107 · doi:10.1111/1469-0691.12107
- Peuchant, 2009, Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis, J. Antimicrob. Chemother., 64, 52, 10.1093/jac/dkp160 · DOI
- Pucci, 2011, In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens, Antimicrob. Agents Chemother., 55, 2860, 10.1128/AAC.01666-10 · DOI
- Rocha, 2002, Genomic repeats, genome plasticity and the dynamics of Mycoplasma evolution, Nucleic Acids Res., 30, 2031, 10.1093/nar/30.9.2031 · DOI · Paper page
- Sader, 2012, Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs), J. Antimicrob. Chemother., 67, 1170, 10.1093/jac/dks001 · doi:10.1093/jac/dks001
- Sakata, 2012, Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae, Jpn. J. Antibiot., 65, 173
- Scapini, 2008, Confirmed Mycoplasma pneumoniae endocarditis, Emerging Infect. Dis., 14, 1664, 10.3201/eid1410.080157 · doi:10.3201/eid1410.080157
- Spuesens, 2010, Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing, J. Microbiol. Methods., 82, 214, 10.1016/j.mimet.2010.06.004 · doi:10.1016/j.mimet.2010.06.004
- Spuesens, 2012, Macrolide-resistance determination and molecular typing of Mycoplasma pneumoniae in respiratory specimens collected between 1997 and 2008 in The Netherlands, J. Clin. Microbiol., 50, 1999, 10.1128/JCM.00400-12 · DOI
- Stopler, 1986, Resistance of Mycoplasma pneumoniae to macrolides, lincomycin and streptogramin B, J. Antimicrob. Chemother., 18, 359, 10.1093/jac/18.3.359 · DOI
- Sun, 2013, Multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens and proposal for amendment of MLVA nomenclature, PLoS ONE., 8, e64607, 10.1371/journal.pone.0064607 · DOI
- Suzuki, 2006, Clinical Evaluation of Macrolide-Resistant, Mycoplasma pneumoniae. Antimicrob. Agents Chemother., 50, 709, 10.1128/AAC.50.2.709-712.2006 · DOI · Paper page
- Uldum, 2012, Epidemic of Mycoplasma pneumoniae infection in Denmark, 2010 and 2011, Euro. Surveill., 17, 20073, 10.2807/ese.17.05.20073-en · doi:10.2807/ese.17.05.20073-en
- Waites, 2011, Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas : Approved Guideline.
- Waites, 2013, Chemotherapy of Mycoplasma and Ureaplasma infections
- Waites, 2009, Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101, Antimicrob. Agents Chemother., 53, 2139, 10.1128/AAC.00090-09 · DOI
- Waites, 2015, In vitro antibacterial activity of AZD0914 against human Mycoplasmas and Ureaplasmas, Antimicrob. Agents Chemother., 59, 3627, 10.1128/AAC.04945-14 · doi:10.1128/aac.04945-14
- Wolff, 2008, Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis, Antimicrob. Agents Chemother., 52, 3542, 10.1128/AAC.00582-08 · DOI · Paper page
- Woodhead, 2011, Guidelines for the management of adult lower respiratory tract infections–full version., Clin. Microbiol. Infect., 17, E1, 10.1111/j.1469-0691.2011.03672.x · DOI · Paper page
- Wu, 2013, Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Taiwan, Pediatr. Pulmonol., 48, 904, 10.1002/ppul.22706 · DOI
- Xin, 2009, Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China, Antimicrob. Agents Chemother., 53, 2158, 10.1128/AAC.01563-08 · doi:10.1128/aac.01563-08
- Xue, 2014, Molecular characterizations of PCR-positive Mycoplasma pneumoniae specimens collected from Australia and China, J. Clin. Microbiol., 52, 1478, 10.1128/JCM.03366-13 · doi:10.1128/jcm.03366-13
- Yamada, 2012, Rising rates of macrolide-resistant Mycoplasma pneumoniae in the central United States, Pediatr. Infect. Dis. J., 31, 409, 10.1097/INF.0b013e318247f3e0 · doi:10.1097/inf.0b013e318247f3e0
- Yamazaki, 2007, Activity of garenoxacin against macrolide-susceptible and -resistant Mycoplasma pneumoniae, Antimicrob. Agents Chemother., 51, 2278, 10.1128/AAC.01561-06 · DOI
- Yan, 2015, Comparison of molecular characteristics of Mycoplasma pneumoniae collected from, U.S. and China, J. Clin. Microbiol, 53, 3891, 10.1128/JCM.02468-15 · DOI
- Yan, 2014, A single-tube multiple-locus variable-number tandem-repeat analysis of Mycoplasma pneumoniae clinical specimens by use of multiplex PCR-capillary electrophoresis, J. Clin. Microbiol., 52, 4168, 10.1128/JCM.02178-14 · DOI
- Zhao, 2011, Sequence analysis of the P1 adhesin gene of Mycoplasma pneumoniae in clinical isolates collected in Beijing in 2008 to 2009, J. Clin. Microbiol., 49, 3000, 10.1128/JCM.00105-11 · DOI
- Zhao, 2013a, Multiple-locus variable-number tandem-repeat analysis of 201 Mycoplasma pneumoniae isolates from Beijing, China, from 2008 to 2011, J. Clin. Microbiol., 51, 636, 10.1128/JCM.02567-12 · doi:10.1128/jcm.02567-12
- Zhao, 2013b, Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012, Antimicrob. Agents Chemother., 57, 1521, 10.1128/AAC.02060-12 · DOI
- Zheng, 2015, Macrolide-resistant Mycoplasma pneumoniae, United States, Emerg. Infect. Dis., 21, 1470, 10.3201/eid2108.150273 · doi:10.3201/eid2108.150273
- Zhou, 2014, More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia, Antimicrob. Agents Chemother., 58, 1034, 10.1128/AAC.01806-13 · doi:10.1128/aac.01806-13
- Zhou, 2015, Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China, Antimicrob. Agents Chemother., 59, 1048, 10.1128/AAC.04308-14 · doi:10.1128/aac.04308-14
Cited by
Advances in adhesion-related pathogenesis in Mycoplasma pneumoniae infection
Sun, B., Ling, Y., Li, J., Ma, L., Jie, Z., Luo, H., Li, Y., Yin, G., Wang, M., Meng, F., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1613760 · Cited by 18
Metadata
- Authors
- Pereyre, S., Goret, J., & Bébéar, C.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2016-06-22
- Volume
- 7
- ISSN
- 1664-302X
- Cited by
- 272
- References
- 0
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.